Literature DB >> 8781768

Abnormal Na+/H+ antiport activity in cultured fibroblasts from NIDDM patients with hypertension and microalbuminuria.

R Trevisan1, M R Cipollina, E Duner, M Trevisan, R Nosadini.   

Abstract

An increased activity of Na+/H+ antiport has been reported in leukocytes and fibroblasts from insulin-dependent diabetic (IDDM) patients with nephropathy. To test whether a similar abnormality is present in fibroblasts from non-insulin-dependent diabetic (NIDDM) patients with microalbuminuria and hypertension, we examined intracellular pHi and Na+/H+ antiport activity, using the pH sensitive dye 2', 7'-bis (2-carboxyethyl-5(6)-carboxyfluorescein (BCECF), in cultured skin fibroblasts obtained from 34 NIDDM patients, divided into four groups based upon whether they had microalbuminuria or hypertension, or both: Group 1, nine NIDDM patients with microalbuminuria and hypertension. Group 2, nine NIDDM patients with hypertension and normal albumin excretion rate. Group 3, seven NIDDM patients with microalbuminuria and normal blood pressure. Group 4, nine NIDDM patients with normal blood pressure and normal albumin excretion rate. Nine normal subjects served as control group. Resting pHi was more alkaline in fibroblasts from Group 1 (7.22 +/- 0.03; p < 0.05), Group 2 (7.21 +/- 0.02; p < 0.05) and Group 3 (7.19 +/- 0.02, p = 0.17) than in Group 4 and normal subjects. This was due to higher Vmax values of Na+/H+ antiport activity in cultured fibroblasts from Group 1 (52.1 +/- 5.3 mmol H+/min; p < 0.05), Group 2 (57.7 +/- 8.3; p < 0.05) and Group 3 (60.6 +/- 7.4, p < 0.05) than those from Group 4 (31.2 +/- 3.6) or control subjects (31.3 +/- 3.5). The intracellular pH for half-maximal activation, Hill coefficient and buffering power capacity was similar in all the groups. These data suggest that in vitro phenotypic abnormalities of long-term cultured fibroblasts from NIDDM patients with microalbuminuria and/ or hypertension are likely to be, at least in part, independent of the degree of metabolic control in vivo and to be an intrinsic feature of these cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781768     DOI: 10.1007/bf00418544

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  45 in total

1.  On the impact of hypertension on the prognosis of NIDDM. Results of the Schwabing GP-Program.

Authors:  E Standl; H Stiegler; R Roth; K Schulz; W Lehmacher
Journal:  Diabete Metab       Date:  1989

2.  Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

Authors:  A S Krolewski; M Canessa; J H Warram; L M Laffel; A R Christlieb; W C Knowler; L I Rand
Journal:  N Engl J Med       Date:  1988-01-21       Impact factor: 91.245

3.  Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy.

Authors:  R Mangili; J J Bending; G Scott; L K Li; A Gupta; G Viberti
Journal:  N Engl J Med       Date:  1988-01-21       Impact factor: 91.245

4.  Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors:  A Schmitz; M Vaeth
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

Review 5.  Mechanisms of active H+ secretion in the proximal tubule.

Authors:  P S Aronson
Journal:  Am J Physiol       Date:  1983-12

6.  Leucocyte Na+/H+ antiport activity in type 1 (insulin-dependent) diabetic patients with nephropathy.

Authors:  L L Ng; D Simmons; V Frighi; M C Garrido; J Bomford; T D Hockaday
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

7.  Intracellular pH and Na+/H+ antiport activity of cultured skin fibroblasts from diabetics.

Authors:  J E Davies; L L Ng; A Kofoed-Enevoldsen; L K Li; K A Earle; R Trevisan; G Viberti
Journal:  Kidney Int       Date:  1992-11       Impact factor: 10.612

8.  Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport.

Authors:  R Trevisan; R Nosadini; P Fioretto; A Semplicini; V Donadon; A Doria; G Nicolosi; D Zanuttini; M R Cipollina; L Lusiani
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

9.  Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy.

Authors:  K Earle; J Walker; C Hill; G Viberti
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

10.  Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM.

Authors:  J Fujita; K Tsuda; M Seno; H Obayashi; I Fukui; Y Seino
Journal:  Diabetes Care       Date:  1994-09       Impact factor: 19.112

View more
  1 in total

Review 1.  Is it possible to predict diabetic kidney disease?

Authors:  S M Thomas; G C Viberti
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.